The Council of Medical Specialty Societies’ new ethical code aims to limit drug and device company influence over patient care.
The CMSS Code for Interaction with Companies, released April 20 by the Council of Medical Specialty Societies, is designed to keep medical societies’ interactions with pharmaceutical and medical device companies ethical and transparent. The code, which is voluntary, was formally adopted by 13 of CMSS’s 32 medical society members at the time of its release; more plan to adopt it in the near future, while others already plan to meet or exceed the code’s principles, according to a statement ...
Register for Complete Access (Valid Email Required)
By registering on MeetingsNet now, you'll not only unlock the CMSS Releases New Medical Ethics Code, you'll also gain access to exclusive premium content.